Home › Calculator › VIR Dividend Calculator 2026
VIR Dividend DRIP Calculator 2026
23.01% YieldHealthcareVir Biotechnology, Inc. · NASDAQ
Price: $8.69 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When VIR pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your VIR snowball 📈
$10,000 in VIR → $151.7K in 10 years · $5,827.19/month
About Vir Biotechnology, Inc. (VIR) — Dividend Analysis 2026
Vir Biotechnology, Inc. operates as an immunology company with commercialized products, dedicated to devising therapeutic solutions for the treatment and prevention of significant infectious diseases. Its pipeline features several key candidates: Sotrovimab (branded as Xevudy, or VIR-7832), a neutralizing monoclonal antibody for both treating and preventing SARS-CoV-2 infection; VIR-2218 and VIR-3434, aimed at hepatitis B virus; VIR-2482, targeting the prevention of influenza A virus; and VIR-1111, designed to prevent human immunodeficiency virus. The firm maintains a robust network of strategic partnerships and collaborations. These include grant support from organizations like the Bill & Melinda Gates Foundation and the National Institutes of Health. It holds option and licensing arrangements with entities such as Brii Biosciences Limited, and a collaboration and license agreement with Alnylam Pharmaceuticals, Inc. Further licensing relationships exist with The Rockefeller University and MedImmune, Inc. Collaborations extend to WuXi Biologics and Glaxo Wellcome UK Ltd., alongside a research agreement with GlaxoSmithKline Biologicals SA. Furthermore, Vir has secured a manufacturing contract with Samsung Biologics Co.,Ltd. for SARS-CoV-2 antibodies and a clinical development partnership with Gilead Sciences, Inc. focused on chronic hepatitis B virus. The company, established in 2016, is headquartered in San Francisco, California.
Compare VIR with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full VIR DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open VIR position with:
🌍 VIR Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold VIR.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 23.01% | 20.21% | $2,301 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 19.56% | 16.76% | $1,956 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 18.41% | 15.61% | $1,841 / yr |
| 🇬🇧 UK ISA | 0% | 23.01% | 20.21% | $2,301 / yr |
| 🇬🇧 UK Taxable | 8.75% | 21.00% | 18.20% | $2,100 / yr |
| 🇨🇦 TFSA | 0% | 23.01% | 20.21% | $2,301 / yr |
| 🇨🇦 CA Taxable | 25% | 17.26% | 14.46% | $1,726 / yr |
| 🇦🇺 Super (pension) | 15% | 19.56% | 16.76% | $1,956 / yr |
| 🇦🇺 AU Taxable | 30% | 16.11% | 13.31% | $1,611 / yr |
| 🇩🇪 DE Taxable | 26.375% | 16.94% | 14.14% | $1,694 / yr |
| 🇫🇷 FR Taxable | 30% | 16.11% | 13.31% | $1,611 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 VIR Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 VIR Dividend Payment Schedule
VIR pays quarterly — 4 times per year. Next ex-div: TBD.
📊 VIR vs Healthcare Benchmarks
How VIR compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for VIR sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ VIR Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-09 | 8,000 | — | — | ||
| A-Award | 2026-06-09 | 16,000 | $8.51 | $136.2K | ||
| A-Award | 2026-06-09 | 8,000 | — | — | ||
| Sale | 2026-06-01 | 3,200 | $9.45 | $30.2K | ||
| Sale | 2026-06-01 | 379 | $9.45 | $3.6K | ||
| A-Award | 2026-05-27 | 8,000 | — | — | ||
| A-Award | 2026-05-27 | 16,000 | $9.10 | $145.6K | ||
| A-Award | 2026-05-27 | 8,000 | — | — | ||
| A-Award | 2026-05-27 | 16,000 | $9.10 | $145.6K | ||
| A-Award | 2026-05-27 | 8,000 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where VIR earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the VIR dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Vir Biotechnology, Inc. (VIR) is currently trading at $8.69, 87% below its 52-week high. The current dividend yield is 23.01% based on an annual payout of $2.00 per share.
VIR (Vir Biotechnology, Inc.) — 23.01% Dividend Yield Analysis
Vir Biotechnology, Inc. (VIR) is a healthcare stock currently trading at $8.69 with a dividend yield of 23.01%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (23.01%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.